+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Latanoprost for Open-angle Glaucoma Market - Global Forecast 2025-2030- Product Image
Latanoprost for Open-angle Glaucoma Market - Global Forecast 2025-2030- Product Image
Sale

Latanoprost for Open-angle Glaucoma Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 199 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6118345
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Senior leaders evaluating the latanoprost market for glaucoma care face crucial shifts in patient needs, technology, and policy. This B2B research delivers tailored, actionable insights to help executives navigate transformation, optimize value propositions, and sustain competitive advantage.

Market Snapshot: Latanoprost Market Landscape

The latanoprost market for open-angle glaucoma is experiencing dynamic change, driven by innovation in formulations, delivery technologies, and global supply chain strategies. Growth is shaped by increased diagnosis rates and evolving patient preferences, while both branded and generic manufacturers actively compete through technological advancements and strategic services.

Scope & Segmentation

This comprehensive report analyzes the latanoprost market across product types, applications, and global regions with a focus on key innovations.

  • Formulation Types: Preservative-free, standard eye drops, sustained-release solutions
  • Therapeutic Applications: Combination therapy, monotherapy
  • Product Categories: Branded, generic
  • Strength Variations: 0.005%, 0.0075%
  • Distribution Channels: Hospital, online, and retail pharmacies (chain and independent)
  • End Users: Clinics, home care, hospitals
  • Age Groups: Adults, geriatrics, pediatric patients
  • Regional Coverage: Americas (with detailed analysis for United States: California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio, plus Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Participating Companies: Pfizer Inc., Santen Pharmaceutical Co., Ltd., Novartis AG, Viatris Inc., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Cipla Ltd., Aurobindo Pharma Limited, Lupin Limited, Dr. Reddy's Laboratories Limited
  • Technology Trends: Preservative-free technologies, sustained-release delivery, digital adherence monitoring, teleophthalmology, regional supply optimization

Key Takeaways for Decision-Makers

  • Preservative-free and sustained-release innovations are reshaping patient and provider expectations for safety, tolerability, and ease of use.
  • Adoption of digital health tools, such as smart dispensers and remote monitoring, enhances patient engagement and supports personalized care models.
  • Competitive intensity has increased as generic entrants leverage pricing strategies, pushing branded developers to invest in differentiation and patient support services.
  • Strategic collaborations with digital health providers, academic partners, and contract manufacturers are catalyzing pipeline development and accelerating market access.
  • Regional strategies must account for varying regulatory dynamics, reimbursement structures, and distribution infrastructures to optimize penetration.
  • Portfolio diversification, particularly in combination regimens, enables growth by meeting the clinical needs of more complex glaucoma cases.

Tariff Impact: 2025 U.S. Policy Intervention

Upcoming tariff changes in the U.S. for 2025 are set to influence pricing structures throughout the latanoprost supply chain. Increased duties on imported active pharmaceutical ingredients and finished products will elevate procurement and distribution costs. Domestic operations may see temporary relief, while organizations with integrated supply chains gain agility in absorbing shocks. Proactive engagement with customs authorities, exploring bonded warehousing, and multilateral sourcing agreements are recommended interventions to safeguard affordability and continuity.

Primary Keyword: Latanoprost Market Dynamics

The latanoprost market is evolving as manufacturers respond to shifting treatment paradigms, cost pressures, and the integration of patient-centric technologies.

Methodology & Data Sources

Analysis combines primary interviews with ophthalmology leaders, regulatory experts, and supply chain managers, supported by secondary review of clinical journals, patent filings, and policy documents. Robust data triangulation, advanced analytics, and external validation deliver reliable, actionable intelligence.

Why This Report Matters

  • Identify innovation levers in formulation, delivery, and patient support to inform portfolio optimization and commercialization strategies.
  • Understand evolving regulatory and reimbursement trends to align entry and pricing models with regional market realities.
  • Leverage real-world evidence and digital health integration to strengthen stakeholder engagement and secure long-term value creation.

Conclusion

Senior decision-makers gain strategic clarity to address complexity in the latanoprost market, driving growth through differentiation, supply resilience, and adaptive commercial models. This report supports optimal positioning by blending market insight with operational guidance.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rising competition from generic latanoprost and its impact on pricing and market penetration
5.2. Increasing shift toward preservative-free latanoprost eye drops to address ocular surface toxicity
5.3. Expansion of fixed-dose combinations of latanoprost with other agents for enhanced intraocular pressure control
5.4. Emergence of extended-release intracanalicular implants delivering latanoprost for improved patient adherence
5.5. Growing emphasis on patient support programs to improve adherence to latanoprost therapy and outcomes
5.6. Integration of teleophthalmology monitoring tools for latanoprost-treated glaucoma patients
5.7. Growing investment in biosimilar latanoprost development by emerging pharmaceutical companies
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Latanoprost for Open-angle Glaucoma Market, by Formulation
8.1. Introduction
8.2. Preservative Free
8.3. Standard Eye Drop
8.4. Sustained Release
9. Latanoprost for Open-angle Glaucoma Market, by Application
9.1. Introduction
9.2. Combination Therapy
9.3. Monotherapy
10. Latanoprost for Open-angle Glaucoma Market, by Product Category
10.1. Introduction
10.2. Branded
10.3. Generic
11. Latanoprost for Open-angle Glaucoma Market, by Strength
11.1. Introduction
11.2. 0.005%
11.3. 0.0075%
12. Latanoprost for Open-angle Glaucoma Market, by Distribution Channel
12.1. Introduction
12.2. Hospital Pharmacy
12.3. Online Pharmacy
12.4. Retail Pharmacy
12.4.1. Chain Pharmacy
12.4.2. Independent Pharmacy
13. Latanoprost for Open-angle Glaucoma Market, by End User
13.1. Introduction
13.2. Clinics
13.3. Home Care
13.4. Hospitals
14. Latanoprost for Open-angle Glaucoma Market, by Age Group
14.1. Introduction
14.2. Adults
14.3. Geriatric
14.4. Pediatric
15. Americas Latanoprost for Open-angle Glaucoma Market
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. Argentina
16. Europe, Middle East & Africa Latanoprost for Open-angle Glaucoma Market
16.1. Introduction
16.2. United Kingdom
16.3. Germany
16.4. France
16.5. Russia
16.6. Italy
16.7. Spain
16.8. United Arab Emirates
16.9. Saudi Arabia
16.10. South Africa
16.11. Denmark
16.12. Netherlands
16.13. Qatar
16.14. Finland
16.15. Sweden
16.16. Nigeria
16.17. Egypt
16.18. Turkey
16.19. Israel
16.20. Norway
16.21. Poland
16.22. Switzerland
17. Asia-Pacific Latanoprost for Open-angle Glaucoma Market
17.1. Introduction
17.2. China
17.3. India
17.4. Japan
17.5. Australia
17.6. South Korea
17.7. Indonesia
17.8. Thailand
17.9. Philippines
17.10. Malaysia
17.11. Singapore
17.12. Vietnam
17.13. Taiwan
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. Pfizer Inc.
18.3.2. Santen Pharmaceutical Co., Ltd.
18.3.3. Novartis AG
18.3.4. Viatris Inc.
18.3.5. Teva Pharmaceutical Industries Ltd.
18.3.6. Sun Pharmaceutical Industries Ltd.
18.3.7. Cipla Ltd.
18.3.8. Aurobindo Pharma Limited
18.3.9. Lupin Limited
18.3.10. Dr. Reddy's Laboratories Limited
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY PRODUCT CATEGORY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY PRODUCT CATEGORY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY STRENGTH, 2024 VS 2030 (%)
FIGURE 12. GLOBAL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY STRENGTH, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
FIGURE 18. GLOBAL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 29. LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET: RESEARCHAI
FIGURE 30. LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET: RESEARCHSTATISTICS
FIGURE 31. LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET: RESEARCHCONTACTS
FIGURE 32. LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY PRESERVATIVE FREE, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY PRESERVATIVE FREE, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY STANDARD EYE DROP, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY STANDARD EYE DROP, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY SUSTAINED RELEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY SUSTAINED RELEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY COMBINATION THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY COMBINATION THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY MONOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY MONOTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY PRODUCT CATEGORY, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY PRODUCT CATEGORY, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY BRANDED, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY BRANDED, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY GENERIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY GENERIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY 0.005%, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY 0.005%, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY 0.0075%, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY 0.0075%, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY HOME CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY HOME CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY ADULTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY ADULTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY GERIATRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY PRODUCT CATEGORY, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY PRODUCT CATEGORY, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY PRODUCT CATEGORY, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY PRODUCT CATEGORY, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 101. CANADA LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 102. CANADA LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 103. CANADA LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 104. CANADA LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 105. CANADA LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY PRODUCT CATEGORY, 2018-2024 (USD MILLION)
TABLE 106. CANADA LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY PRODUCT CATEGORY, 2025-2030 (USD MILLION)
TABLE 107. CANADA LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 108. CANADA LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 109. CANADA LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 110. CANADA LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 111. CANADA LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 112. CANADA LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 113. CANADA LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 114. CANADA LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 115. CANADA LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 116. CANADA LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 117. MEXICO LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 118. MEXICO LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 119. MEXICO LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 120. MEXICO LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 121. MEXICO LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY PRODUCT CATEGORY, 2018-2024 (USD MILLION)
TABLE 122. MEXICO LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY PRODUCT CATEGORY, 2025-2030 (USD MILLION)
TABLE 123. MEXICO LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 124. MEXICO LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 125. MEXICO LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 126. MEXICO LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 127. MEXICO LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 128. MEXICO LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 129. MEXICO LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 130. MEXICO LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 131. MEXICO LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 132. MEXICO LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 133. BRAZIL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 134. BRAZIL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 135. BRAZIL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 136. BRAZIL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 137. BRAZIL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY PRODUCT CATEGORY, 2018-2024 (USD MILLION)
TABLE 138. BRAZIL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY PRODUCT CATEGORY, 2025-2030 (USD MILLION)
TABLE 139. BRAZIL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 140. BRAZIL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 141. BRAZIL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 142. BRAZIL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 143. BRAZIL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 144. BRAZIL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 145. BRAZIL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 146. BRAZIL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 147. BRAZIL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 148. BRAZIL LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 149. ARGENTINA LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 150. ARGENTINA LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 151. ARGENTINA LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 152. ARGENTINA LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 153. ARGENTINA LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY PRODUCT CATEGORY, 2018-2024 (USD MILLION)
TABLE 154. ARGENTINA LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY PRODUCT CATEGORY, 2025-2030 (USD MILLION)
TABLE 155. ARGENTINA LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 156. ARGENTINA LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 157. ARGENTINA LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 158. ARGENTINA LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 159. ARGENTINA LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 160. ARGENTINA LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 161. ARGENTINA LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 162. ARGENTINA LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 163. ARGENTINA LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 164. ARGENTINA LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY PRODUCT CATEGORY, 2018-2024 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY PRODUCT CATEGORY, 2025-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 183. UNITED KINGDOM LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 184. UNITED KINGDOM LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 186. UNITED KINGDOM LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY PRODUCT CATEGORY, 2018-2024 (USD MILLION)
TABLE 188. UNITED KINGDOM LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY PRODUCT CATEGORY, 2025-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 190. UNITED KINGDOM LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 192. UNITED KINGDOM LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 194. UNITED KINGDOM LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 196. UNITED KINGDOM LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 198. UNITED KINGDOM LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 199. GERMANY LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 200. GERMANY LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 201. GERMANY LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 202. GERMANY LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 203. GERMANY LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY PRODUCT CATEGORY, 2018-2024 (USD MILLION)
TABLE 204. GERMANY LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY PRODUCT CATEGORY, 2025-2030 (USD MILLION)
TABLE 205. GERMANY LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 206. GERMANY LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 207. GERMANY LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 208. GERMANY LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 209. GERMANY LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 210. GERMANY LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 211. GERMANY LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 212. GERMANY LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 213. GERMANY LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 214. GERMANY LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 215. FRANCE LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 216. FRANCE LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 217. FRANCE LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 218. FRANCE LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 219. FRANCE LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY PRODUCT CATEGORY, 2018-2024 (USD MILLION)
TABLE 220. FRANCE LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY PRODUCT CATEGORY, 2025-2030 (USD MILLION)
TABLE 221. FRANCE LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 222. FRANCE LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 223. FRANCE LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 224. FRANCE LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 225. FRANCE LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 226. FRANCE LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 227. FRANCE LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 228. FRANCE LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 229. FRANCE LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 230. FRANCE LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 231. RUSSIA LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 232. RUSSIA LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 233. RUSSIA LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 234. RUSSIA LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 235. RUSSIA LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY PRODUCT CATEGORY, 2018-2024 (USD MILLION)
TABLE 236. RUSSIA LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY PRODUCT CATEGORY, 2025-2030 (USD MILLION)
TABLE 237. RUSSIA LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 238. RUSSIA LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 239. RUSSIA LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 240. RUSSIA LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 241. RUSSIA LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 242. RUSSIA LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 243. RUSSIA LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 244. RUSSIA LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 245. RUSSIA LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 246. RUSSIA LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 247. ITALY LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 248. ITALY LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 249. ITALY LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 250. ITALY LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 251. ITALY LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY PRODUCT CATEGORY, 2018-2024 (USD MILLION)
TABLE 252. ITALY LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY PRODUCT CATEGORY, 2025-2030 (USD MILLION)
TABLE 253. ITALY LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 254. ITALY LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 255. ITALY LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 256. ITALY LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 257. ITALY LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 258. ITALY LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 259. ITALY LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 260. ITALY LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 261. ITALY LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 262. ITALY LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 263. SPAIN LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 264. SPAIN LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 265. SPAIN LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 266. SPAIN LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 267. SPAIN LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY PRODUCT CATEGORY, 2018-2024 (USD MILLION)
TABLE 268. SPAIN LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY PRODUCT CATEGORY, 2025-2030 (USD MILLION)
TABLE 269. SPAIN LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 270. SPAIN LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 271. SPAIN LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 272. SPAIN LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 273. SPAIN LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 274. SPAIN LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 275. SPAIN LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 276. SPAIN LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 277. SPAIN LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 278. SPAIN LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 279. UNITED ARAB EMIRATES LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 280. UNITED ARAB EMIRATES LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 281. UNITED ARAB EMIRATES LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 282. UNITED ARAB EMIRATES LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 283. UNITED ARAB EMIRATES LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY PRODUCT CATEGORY, 2018-2024 (USD MILLION)
TABLE 284. UNITED ARAB EMIRATES LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY PRODUCT CATEGORY, 2025-2030 (USD MILLION)
TABLE 285. UNITED ARAB EMIRATES LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 286. UNITED ARAB EMIRATES LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 287. UNITED ARAB EMIRATES LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 288. UNITED ARAB EMIRATES LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 289. UNITED ARAB EMIRATES LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 290. UNITED ARAB EMIRATES LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 291. UNITED ARAB EMIRATES LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 292. UNITED ARAB EMIRATES LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 293. UNITED ARAB EMIRATES LATANOPROST FOR OPEN-ANGLE GLAUCOMA MARKET SIZE, BY AGE GROU

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Latanoprost for Open-angle Glaucoma market report include:
  • Pfizer Inc.
  • Santen Pharmaceutical Co., Ltd.
  • Novartis AG
  • Viatris Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Cipla Ltd.
  • Aurobindo Pharma Limited
  • Lupin Limited
  • Dr. Reddy's Laboratories Limited

Related Topics

Related Reports

Latanoprost & Timolol Ophthalmic Solution Market - Global Forecast 2025-2030 - Product Image

Latanoprost & Timolol Ophthalmic Solution Market - Global Forecast 2025-2030

  • Report
  • 193 Pages
  • Global
From
Open-Angle Glaucoma Therapeutics Market - Global Forecast 2025-2032 - Product Image

Open-Angle Glaucoma Therapeutics Market - Global Forecast 2025-2032

  • Report
  • 181 Pages
  • Global
From
Glaucoma Market Report 2025 - Product Image

Glaucoma Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Latanoprost Lactone Diol (CAS 145667-75-0) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Latanoprost Lactone Diol (CAS 145667-75-0) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Open-Angle Glaucoma (OAG) Market Report 2025 - Product Image

Open-Angle Glaucoma (OAG) Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.